Board Name | Posts By SForce | Post Created |
---|---|---|
ZRFY Zerify Inc | Says google play and app store with | 05/29/2019 4:03:10 PM |
ZRFY Zerify Inc | Say what?? :) :) :) | 05/02/2019 9:05:56 AM |
ZRFY Zerify Inc | Q2 is when im out. Dont care if at (4) | 04/22/2019 9:29:05 PM |
ZRFY Zerify Inc | Baldeagle, option one appears to be | 02/21/2019 1:44:08 PM |
ZRFY Zerify Inc | I'm in full agreement 4sleddogs. I (5) | 02/21/2019 10:47:00 AM |
ZRFY Zerify Inc | Longbord, SFOR is possibly the best (2) | 02/21/2019 8:32:42 AM |
ZRFY Zerify Inc | I agree Puglista. Came in the trips | 02/21/2019 6:45:39 AM |
ZRFY Zerify Inc | Has anyone emailed Mark? | 02/19/2019 1:05:42 PM |
ZRFY Zerify Inc | WE NEED REVENUES NOW! AND HONESTLY | 02/19/2019 1:04:45 PM |
ZRFY Zerify Inc | "Every software application that ha (1) | 02/15/2019 11:28:24 PM |
ZRFY Zerify Inc | Need help with MobileTrust. I dont | 08/18/2018 1:12:56 PM |
ZRFY Zerify Inc | Does anyone know what time we'll se | 08/14/2018 12:31:33 PM |
ZRFY Zerify Inc | LLC Incorporated 8/17/2016. New Jer | 05/08/2018 9:18:54 AM |
Recent Articles
- Risks and Opportunities for Light & Wonder, Inc. Investors
- Teva's Leadership to Discuss Innovations at Upcoming Conference
- Celebrating Thanksgiving with Free Turkeys and Unique Feasts
- Understanding Acadia Healthcare's Recent Legal Challenges
- Investors Urged to Take Action in Chipotle Class Action Case
- Warren Buffett's Heartfelt Philanthropy: Insights from His Legacy
- Innovative AI Training Solutions by Boys Town Transform Lives
- Heartland Express to Showcase Expertise at Major Conference
- Lilium N.V. Class Action Alerts Investors on Critical Deadline
- Investors Urged to Act in TMC Class Action Lawsuit Notice
- Biden’s Pardons: A Call for Cannabis Justice This Season
- Rackspace Technology's Upcoming Presentation at AI Conference
- Brian Buffini and Dr. Yun to Unveil 2025 Housing Insights
- LexinFintech Holdings Delivers Impressive Q3 2024 Financial Performance
- LeMaitre Vascular Engages Investors with Upcoming Conferences
- Hims & Hers Health Stock Surge Fueled by FDA Nomination Buzz
- Clearway Energy Expands Portfolio with New Wind Project Acquisition
- Marqeta, Inc. Investors Urged to Explore Legal Options
- Exciting Insights on Palazestrant and Ribociclib Presentation
- OnKure Therapeutics Schedules Investor Call for Key Updates
- Exciting Breakthroughs in Breast Cancer Treatment by Arvinas
- Steel Keg Association Promotes Reusable Kegs Amid Leadership Change
- Investors Urged to Join Humacyte, Inc. Class Action Lawsuit
- Minnesota's Cannabis Lottery Delayed Amid Legal Challenges
- Kohl's Welcomes Ashley Buchanan as CEO to Foster Growth
- State Street's $2.25 Billion Debt: Fostering Inclusion in Finance
- Faraday Future Reinvents Its Stock Symbol to Emphasize AI
- Golub Capital BDC Introduces Major $150 Million Note Offering
- HPH Sees Board Changes Amid Strategic Transformation
- Eastman Kodak's Strategic Pension Plan Move and Market Impact
- HPH Announces Leadership Transition and Future Focus
- SpaceX to Launch NASA's Dragonfly Mission to Titan
- Clairvest's New Partnership with Redstone Food Group
- Automotive Properties REIT Acquires Key Montreal Rental Properties
- Tim Draper Enthusiastically Predicts Bitcoin's Striking Rise
- Hennessy Advisors' ESG ETF to Transfer Listings to Nasdaq
- Agora, Inc. Sees Strategic Shifts Amid Financial Adjustments
- Hesai Group Announces Impressive Q3 2024 Financial Growth
- Creative Global Technology Holdings' Upcoming IPO Details
- Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
- Analyzing Woodward's Q4 Earnings and Future Outlook
- Blue Bird's Financial Performance in the Latest Earnings Report
- Central Garden & Pet Reports Strong Q4 Earnings Performance
- Central Garden & Pet's Strong Q4 Earnings Highlights
- Enanta Pharma's Earnings Report Highlights for Investors in 2024
- Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
- Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
- Leslie's Performance in Q4: Key Insights and Future Prospects
- Exploring Central Garden & Pet's Recent Earnings Performance
- Insights into Enanta Pharma's Q4 Earnings Performance